Quick Heal Technologies Ltd is Rated Strong Sell

Jan 15 2026 10:10 AM IST
share
Share Via
Quick Heal Technologies Ltd is rated Strong Sell by MarketsMojo. This rating was last updated on 02 December 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are based on the company’s current position as of 15 January 2026, providing investors with the latest insights into its performance and prospects.
Quick Heal Technologies Ltd is Rated Strong Sell



Current Rating and Its Significance


The Strong Sell rating assigned to Quick Heal Technologies Ltd indicates a cautious stance for investors. This rating suggests that the stock is expected to underperform relative to the broader market and peers in the near to medium term. Investors should consider this recommendation as a signal to avoid new purchases or to consider reducing existing exposure, given the prevailing risks and challenges identified in the company’s financial and market profile.



Quality Assessment


As of 15 January 2026, Quick Heal Technologies Ltd holds an average quality grade. This reflects a middling performance in terms of business fundamentals such as revenue growth, profitability consistency, and operational efficiency. The company’s net sales have experienced a negative compound annual growth rate of -0.80% over the past five years, signalling stagnation or decline in core business expansion. Operating profit has deteriorated sharply, with a decline of -179.58% over the same period, highlighting significant challenges in maintaining profitability.



Valuation Perspective


The valuation grade for Quick Heal Technologies Ltd is currently assessed as risky. The stock is trading at levels that suggest elevated risk compared to its historical averages. Negative EBITDA and shrinking cash reserves, with cash and cash equivalents at a low ₹6.84 crores as of the latest half-year results, contribute to this cautious valuation stance. The company’s price performance has been weak, with a one-year return of -59.64%, underscoring investor concerns about its earnings sustainability and growth prospects.



Financial Trend Analysis


The financial trend for Quick Heal Technologies Ltd is described as flat. Recent results show a lack of meaningful improvement or deterioration in key financial metrics. The latest six-month profit after tax (PAT) stands at ₹2.40 crores, reflecting a decline of -70.66%. Debtors turnover ratio is at a low 1.57 times, indicating potential issues in receivables management. Institutional investor participation has also waned, with a reduction of -0.91% in their stake over the previous quarter, now holding just 2.83% of the company. This decline in institutional interest often signals reduced confidence from sophisticated market participants.



Technical Outlook


The technical grade for the stock is bearish. Price trends over multiple time frames confirm a downtrend, with the stock losing -13.80% over the past week, -19.43% in one month, and -26.74% over three months. The six-month decline is even more pronounced at -40.15%. These figures indicate sustained selling pressure and weak market sentiment. The stock’s underperformance relative to the BSE500 index over the last three years, one year, and three months further reinforces the negative technical outlook.



Summary of Current Position


In summary, Quick Heal Technologies Ltd’s Strong Sell rating is supported by a combination of average business quality, risky valuation metrics, flat financial trends, and bearish technical indicators. The company faces significant headwinds in terms of profitability, cash flow, and investor confidence. For investors, this rating serves as a cautionary signal to reassess exposure and consider alternative opportunities with stronger fundamentals and more favourable market dynamics.




Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.



  • - Investment Committee approved

  • - 50+ candidates screened

  • - Strong post-announcement performance


See Why It Was Chosen →




Investor Considerations and Outlook


Investors should note that the current rating and analysis reflect the company’s position as of 15 January 2026, providing a timely snapshot of its financial health and market performance. The persistent decline in returns, with a one-year loss of -59.64%, and deteriorating profitability metrics suggest that Quick Heal Technologies Ltd is facing structural challenges that may take time to resolve.



Given the flat financial trend and bearish technical signals, the stock may continue to experience volatility and downward pressure in the near term. The reduced participation by institutional investors further emphasises the need for caution, as these investors typically possess deeper analytical resources and market insight.



For those holding the stock, it is prudent to monitor quarterly results closely and reassess investment theses in light of evolving fundamentals. Prospective investors should weigh the risks carefully and consider whether the current valuation adequately compensates for the uncertainties surrounding the company’s growth and profitability prospects.



Conclusion


Quick Heal Technologies Ltd’s Strong Sell rating by MarketsMOJO is a reflection of its challenging business environment, risky valuation, stagnant financial trends, and negative technical momentum. This comprehensive assessment aims to guide investors in making informed decisions by highlighting the key factors influencing the stock’s outlook as of today.



While the company operates in the software products sector, its recent performance metrics and market behaviour suggest that caution is warranted. Investors seeking exposure to this sector may find more compelling opportunities elsewhere until Quick Heal Technologies Ltd demonstrates a clear turnaround in its fundamentals and market sentiment.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News